Related Experiment Video
Updated: Jul 19, 2026
08:02
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
Platelet-activating factor and human meningiomas.
Neuropathology and Applied Neurobiology
|November 7, 2006
Summary
Platelet-activating factor (PAF) is present in human meningiomas. While its levels did not correlate with tumor characteristics, PAF may influence meningioma growth by affecting angiogenic and cytokine networks.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Meningiomas are common primary intracranial tumors.
- Platelet-activating factor (PAF) is an inflammatory and angiogenic lipid mediator implicated in various cancers.
- Investigating PAF's role in meningiomas is crucial for understanding tumor development.
Discussion:
- This study detected Platelet-Activating Factor Receptor (PAF-R) transcripts, PAF, Phospholipase A2 (PLA2) activity, and PAF Acetylhydrolase (AHA) activity in human meningiomas.
- The levels of these factors did not correlate with tumor grade, edema, necrosis, mitotic index, neovascularization, or chronic inflammation.
- Despite the lack of correlation with specific pathological features, the presence of PAF suggests a potential role in meningioma biology.
Key Insights:
- PAF and its related molecular components are present in human meningiomas.
- PAF's presence suggests a potential involvement in modulating local angiogenic and cytokine networks within the tumor microenvironment.
- The findings align with previous research on PAF's role in breast and colorectal cancers.
Outlook:
- Further research is needed to elucidate the precise mechanisms by which PAF influences meningioma growth and progression.
- Targeting PAF pathways could represent a novel therapeutic strategy for meningioma treatment.
- Investigating the interplay between PAF and other signaling pathways in meningiomas is warranted.
More Related Videos
Related Concept Videos
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...